Pro Nephro AKI (NGAL) is now FDA-Cleared     READ MORE

Acute Kidney Injury

Common in hospitalized patients, increasing in incidence, and associated with adverse outcomes. But, hard to identify.

AKI Risk Factors

Acute kidney injury (AKI) is a rapid loss of kidney function, which typically happens as a complication of another serious illness or intervention. Because pain and other symptoms don’t usually occur, rapid identification of patients who are at riski is critical, as there is no specific treatment for AKI.

Identify AKI earlier with The NGAL Test.

Bioporto Acute Kidney Injury Risk Factors

AKI is Associated with Adverse, Long-Term Outcomes

1 in 5

Hospitalized patients at risk

+7 to 23

Days in hospital

Overall mortality rate
0 %
AKI survivors with one or more kidney abnormalities
0 %

AKI Classification Systems

The definition of AKI, previously known as acute renal failure (ARF), has evolved for nearly two decades, as clinicians have struggled to classify the condition.vi

Developed in 2012, the current KDIGO definition and staging of AKIvii are summarized here. These guidelines are under review with updates expected in 2025.

KDIGO - Kidney Disease Improving Global Outcomes Criteria

StageSerum CreatinineUrine Output
11.5–1.9 times baseline,or ≥0.3 mg/dL >26.5 µmol/L increase<0.5 mL/kg/h for 6-12h
22–2.9 times baseline<0.5 mL/kg/h for ≥12h
33 times baseline, OR Increase in serum creatinine to ≥4 mg/dL, OR Initiation of renal replacement therapy<0.3 mL/kg/h for ≥24h, or anuria for ≥12h

Receive AKI Guideline Updates

Stay up to date on the latest kidney care guideline updates. We’ll issue them as they become available.

AKI Assessment Using Functional and Damage Biomarkers

In 2020, the Acute Disease Quality Initiative (ADQI) workgroup recommended that “a combination of damage and functional biomarkers, along with clinical information, be used to improve the diagnostic accuracy of AKI, to recognize the different pathophysiological processes, to discriminate AKI etiology, and to assess AKI severity.”viii

Neutrophil gelatinase-associated lipocalin (NGAL) is a renal damage biomarker with extensive research in different patient populations and clinical settings.

Bioporto Aki Assessment Functional And Damage Biomarkers